Anti‐B4‐blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma von Grossbard, Michael L., Fidias, Panos, Kinsella, Jeanne, O'toole, John, Lambert, John M., Blattler, Walter A., Esseltine, Dixie, Braman, Ginny, Nadler, Lee M., Anderson, Kenneth C.

Volltext

Supplemental Materials for JAAD Publication JAAD-D-21-01712R3, Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia... von Jim Cassella

Volltext bestellen

Supplemental Materials for JAAD Publication JAAD-D-21-01712R3, Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia... von Jim Cassella

Volltext bestellen

Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuou... von Shah, Sudhir A., Lambert, John M., Goldmacher, Victor S., Esber, Henry J., Levin, James L., Chungi, Vinod, Zutshi, Anup, Braman, Ginny M., Ariniello, Pamela D., Taylor, James A., Blättler, Walter A.

Volltext